Future investigations will focus on the additional biomarkers listed in Table 4 to aid in differentiating breast cancer from control; specifically, SPARC-like protein 1 and lactate dehydrogenase as these markers will provide more insight into ECM remodeling and metabolic processes respectively. Here, SPARCL1 is linked to breast cancer.